|
|
市场分析报告
|
Global Market Report of Fexinidazole (CAS 59729-37-2) December 2024
Chagas Disease - Pipeline Insight, 2019 ... include Seren Pharmaceuticals (Fosravuconazole), Sanofi (Fexinidazole), Celera Genomics Group (K 777), etc ...
African Trypanosomiasis - Pipeline Review, H1 2020 African Trypanosomiasis - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide African Trypanosomiasis - Pipeline Review, H1 2020, provides an overview of the African Trypanosomiasis ( ...
African Trypanosomiasis - Pipeline Review, H2 2020 African Trypanosomiasis - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide African Trypanosomiasis - Pipeline Review, H2 2020, provides an overview of the African Trypanosomiasis ( ...
African Trypanosomiasis (Infectious Disease) - Drugs In Development, 2021 African Trypanosomiasis (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide African Trypanosomiasis - Drugs In Development, 2021, provides an overview of the African ...
African Trypanosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update African Trypanosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide African Trypanosomiasis - Drugs In Development ...
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2020 Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chagas Disease - Pipeline Review, H1 2020, provides an overview of the Chagas Disease ( ...
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2020 Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chagas Disease - Pipeline Review, H2 2020, provides an overview of the Chagas Disease ( ...
Chagas Disease - Pipeline Review, H1 2017 Chagas Disease - Pipeline Review, H1 2017 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides an overview of the Chagas Disease (Infectious Disease) pipeline ...
Chagas Disease (American trypanosomiasis) Drug Development Pipeline Study, H2 2018 Chagas Disease (American trypanosomiasis) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chagas Disease (American trypanosomiasis) pipeline products. DISEASE OVERVIEW Chagas disease, ...
African Trypanosomiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for African Trypanosomiasis African Trypanosomiasis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of African Trypanosomiasis Infection pipeline products. DISEASE OVERVIEW African Trypanosomiasis ...
Chagas Disease (Infectious Disease) - Drugs In Development, 2021 Chagas Disease (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chagas Disease - Drugs In Development, 2021, provides an overview of the Chagas Disease (Infectious ...
Chagas Disease (American Trypanosomiasis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Chagas Disease (American Trypanosomiasis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chagas Disease (American ...
Chagas Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major Chagas disease markets are expected to exhibit a CAGR of 3.19% during 2024-2034. The Chagas disease market has been comprehensively analyzed in IMARC's new report titled "Chagas Disease Market: Epidemiology, Industry Trends, Share, Size, Growth ...
Neglected Tropical Disease Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type ... sickness drugs grow at 2.5%–6.5%, with oral fexinidazole improving access. LeishmaniasesLeishmania treatments grow ...
|
|
|
|